HNF1A-MODY is associated with an intact CRP response during human endotoxaemia

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia

Bibliographic Details
Main Authors:	Mughal, SA, Beatty, S, Chai, J, Shah, N, Smith, D, James, T, Digby, J, McCarthy, M, Owen, K
Format:	Journal article
Published:	2014

Similar Items

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
by: Owen, K, et al.
Published: (2013)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

Altered cortisol metabolism in individuals with HNF1A-MODY
by: Juszczak, A, et al.
Published: (2020)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
by: Mughal, SA, et al.
Published: (2013)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
by: McDonald, T, et al.
Published: (2012)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
by: Nowak, N, et al.
Published: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
by: Nowak, N, et al.
Published: (2013)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
by: Selwood, M, et al.
Published: (2008)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
by: McDonald, T, et al.
Published: (2011)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
by: Juszczak, A, et al.
Published: (2018)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
by: Mughal, SA, et al.
Published: (2013)

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
by: Servitja, J, et al.
Published: (2009)

Induced normothermia ameliorates the procoagulant host response in human endotoxaemia
by: Harmon, MBA, et al.
Published: (2021)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
by: Gloyn, A, et al.
Published: (2011)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
by: Mughal, SA, et al.
Published: (2013)

Early developmental perturbations in a human stem cell model of MODY5/HNF1B pancreatic hypoplasia
by: Teo, Adrian Kee Keong, et al.
Published: (2018)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
by: Harries, L, et al.
Published: (2009)

Effects of chronic endotoxaemia on oxygen consumption at different ambient temperatures in the unanaesthetised rat.
by: Goran, M, et al.
Published: (1988)

HNF4A haploinsufficiency in MODY1 abrogates liver and pancreas differentiation from patient-derived induced pluripotent stem cells
by: Joanita Jasmen, et al.
Published: (2019)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018)

Comparison of prioritisation strategies for selecting subjects with apparent type 1 diabetes for MODY gene sequencing
by: Owen, K, et al.
Published: (2007)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
by: Owen, K, et al.
Published: (2010)

Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
by: Zoldoš, V, et al.
Published: (2012)

The role of the HNF4alpha enhancer in type 2 diabetes.
by: Mitchell, S, et al.
Published: (2002)

A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population.
by: Weedon, M, et al.
Published: (2005)

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes
by: Mitchell, S, et al.
Published: (2002)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Mutations in HNF1A result in marked alterations of plasma glycan profile.
by: Thanabalasingham, G, et al.
Published: (2013)

When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes
by: Althari, S, et al.
Published: (2016)

Diagnosis and management of maturity onset diabetes of the young (MODY).
by: Thanabalasingham, G, et al.
Published: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY).
by: Thanabalasingham, G, et al.
Published: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY)
by: Thanabalasingham, G, et al.
Published: (2011)

Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs
by: Braverman-Gross, C, et al.
Published: (2018)

Assessment of the pathogenicity of the previously reported D526N Hepatocyte Nuclear factor-1 alpha (HNF1A) variant using a combined genetic, in silico and functional approach
by: Hassanali, N, et al.
Published: (2013)

Differential proteome analysis of CRP-activated platelets
by: Garcia, A, et al.
Published: (2005)

Engineering cAMP Receptor Protein (CRP) for improved cell phenotypes during fermentation
by: Chong, Hui Qing
Published: (2013)

Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?
by: Pomytkin, I, et al.
Published: (2015)

Modi and the Indian Diaspora
by: Palit, Parama Sinha
Published: (2020)